Perioperative Fluid Therapy.ppt

Embed Size (px)

Citation preview

  • 8/20/2019 Perioperative Fluid Therapy.ppt

    1/36

    Perioperative Fluid Management

    Oleh

    Hasanuddin

    Pembimbing

    Dr. Abd. Wahab, SpAn

  • 8/20/2019 Perioperative Fluid Therapy.ppt

    2/36

      The principle of uid therapy is tomaintain tissue perfusion

    How much should we inuse! 

    What luids should we use!

    How should we monitor luid replacement!

    So…

  • 8/20/2019 Perioperative Fluid Therapy.ppt

    3/36

    Total Body Water 

    • Total body water varies between 55-70% of BW

    • Depend on : - age

    - se

    !ale " fe!ale #!ore fat$

    • TBW approi!ately 0% of BW

    •  & person of 0 'gs (as 0 0% ) * +

  • 8/20/2019 Perioperative Fluid Therapy.ppt

    4/36

    "ntra #ellular Space

       #  e   l   l  m  e

      m   b  r  a  n  e

       "  n

       t  r  a  v  a  s  c  u   l  a  r   S  p  a  c  e

    RBC

       #  a  p   i   l   l  a  r  $  m  e  m   b  r  a  n  e

    Distribution o bod$ luids

    total bod$ water %&' (W

    )*'

    *' +&'

     a - )+& me/l

    0 -

    + me/l   ,  a  -   )   +   &  m  e  .   /   l

       0  -   +  m  e  .   /   l

    "nterstitial

    Space

    #olloid cr$stalloids

    1lucose solution

     a - 2 me/l

    0 - )*)

    me/l

  • 8/20/2019 Perioperative Fluid Therapy.ppt

    5/36

    ,o!position of flid

    .o!part!ents

     plasma interstitial intracellular 

    CationsNa 140 146 12K 4 4 150Ca 5 3 10Mg 2 1 7

    Anions

    Cl 103 104 3HCO 24 27 10O4 1 1 !H"O4 2 2 116"rotein 16 5 40

  • 8/20/2019 Perioperative Fluid Therapy.ppt

    6/36

    3$pe o Fluid 4oss in Perioperative Periode

    5 (asal luid reuirements

    5 Fluid loses on drainage, istel, maagslang6

    5 7edistributive and evaporativesurgical losses

    5 Fluid shits 83hird space losses65 (leeding

    How much should we inused !

  • 8/20/2019 Perioperative Fluid Therapy.ppt

    7/36

    10 #g $ 4 %lg ' 40 %l

    10 #g $ 2 %lg ' 20 %l

    50 #g $ 1 %lg ' 50 %l

    110 %ls & (r )ggest to *reo*erati+e re(idrate ,it( gl)#osa t(at -an .

    1/ de-rease sel)ler ins)lin resistan-e *ost o*erati 

    2/ n-rease %)s-le ton)s *ost o*erati

    /ole of -1-2

    /e3ire!ents for 70'g !an

  • 8/20/2019 Perioperative Fluid Therapy.ppt

    8/36

  • 8/20/2019 Perioperative Fluid Therapy.ppt

    9/36

    7edistributive and evaporative surgical luid

    losses

    Degree o tissue trauma Additional luidreuirement

    Minimal 8 herniorrhaph$6 & 9 : cc/ ;g/hour  

    Moderate8 cholec$stectom$6

    : 9 + cc/;g/ hour 

    Severe 8 bowel resection6 + 9 2 cc/;g/hour  

  • 8/20/2019 Perioperative Fluid Therapy.ppt

    10/36

    #lass " #lass "" #lass """ #lass "<

    (lood loss =p to >*& >*&?)*&& )*&&?:&&& @:&&&

    (lood loss

    8 '(

  • 8/20/2019 Perioperative Fluid Therapy.ppt

    11/36

    #ourse o h$povolaemic shoc; in absence otherap$

    De.o!pen-sation

    ,o!pen-sation

    Bleeding

    Heart rate%in

    (lood pressure mmHg

    9rreversi-bility

    3hree Shoc; phases

    Bloodpressre

    0

    *&

    )&&

    )*&

  • 8/20/2019 Perioperative Fluid Therapy.ppt

    12/36

    Problems with Perioperative Fluid

    7eplacement

    • We canEt accuratel$ evaluate blood volume

    • We canEt accuratel$ identi$ luid overload

    • We canEt accuratel$ identi$ h$povolemia

    We canEt accuratel$ evaluate tissue perusion

  • 8/20/2019 Perioperative Fluid Therapy.ppt

    13/36

  • 8/20/2019 Perioperative Fluid Therapy.ppt

    14/36

    #omplication

    • 7is;s o inadeuate resuscitation

    4ie?threatening G lactic acidosis, A7F, MOF

     on?atal G thirst$, drows$ness, di$, nausea I

  • 8/20/2019 Perioperative Fluid Therapy.ppt

    15/36

    /estri.tive vs +iberal

  • 8/20/2019 Perioperative Fluid Therapy.ppt

    16/36

    }

  • 8/20/2019 Perioperative Fluid Therapy.ppt

    17/36

  • 8/20/2019 Perioperative Fluid Therapy.ppt

    18/36

  • 8/20/2019 Perioperative Fluid Therapy.ppt

    19/36

    Starling #apillar$ Forces

    5 3wo orces regulate bul; low across capillariesG

     9 H$drostatic 8HP6 and osmotic pressure 8OP6

    5 3hese orces eist in two luid compartmentsG

     9 (lood 8(6 and interstitial luid 8"F6

    Arterial nd

  • 8/20/2019 Perioperative Fluid Therapy.ppt

    20/36

  • 8/20/2019 Perioperative Fluid Therapy.ppt

    21/36

    W(at flid s(old we se >

    5 #r$stalloid solutions 9 "sotonic

     9 H$potonic 9 h$pertonic

    5 #olloid solutions 9 Semi?s$nthetic colloids 9  aturall$ occurring human

     plasma derivatives

  • 8/20/2019 Perioperative Fluid Therapy.ppt

    22/36

    Crystalliod Colloid"ntravascular persistance Poor 1ood

    Haemod$namicstabilisation

    3ransient Prolonged

    7euired inusion volume 4arge Moderate

    7is; o tissue oedema Obvious "nsigniicant

    nhancement o capillar$ perusion

    Poor 1ood

    7is; o anaph$lais  il 4ow to moderate

    Plasma colloid osmotic pressure

    7educed Maintained

    #ost "nepensive pensive

    #r$stalloids and colloids

  • 8/20/2019 Perioperative Fluid Therapy.ppt

    23/36

    T(e CrystalloidsCrystalloids are a gro)* o intra+eno)s l)id in ,(i-( %ay e.

    9oni. soltion

     ? /inger la.tate4 a.etate

     ? @a,l p(ysiologi. #0A% saline$

     ? 6art!anCs soltion

     ? t.

    • ostly iso-os!olar ) isotoni.

    • ,(eap easy to !anfa.tre

    • 6as no i!!nologi. rea.tion

    • ainly .onfined to t(e etra.elllar flid

    @on ioni.

     ? Detrose 5%

     ? altose 20%

     ? t.

    • Distribted to intra.elllar spa.e

  • 8/20/2019 Perioperative Fluid Therapy.ppt

    24/36

    le-trolyte Co%*arison

    Bet,een NaCl 0/8

    Na9

    K9

    Ca9

    Cl!

    a-tate Os%/=las!a 20 5 20* - *00

    /inger +a.tate 2*0 * 20 18 17*

    @a,l 25 - - 25 - *08

  • 8/20/2019 Perioperative Fluid Therapy.ppt

    25/36

    =ra.ti.al .rystalloid t(erapy

    • yo) in)se NaCl 0/8 1000%l: all t(e Na9 ,ill

    re%ain in t(e C;

    • As NaCl is isotoni- t(ere is no -(ange in C;os%olality and no ,ater e$-(ange o--)rs

    a-ross t(e -ell %e%rane

    • NaCl e$*ands C; only

    • ntra+as-)lar +ol)%e ,ill e in-reased y 250%l

  • 8/20/2019 Perioperative Fluid Therapy.ppt

    26/36

    =ra.ti.al .rystalloid t(erapy .ont…

    • yo) in)se gl)-ose 58 1000%l: t(e gl)-ose

    ,ill enter t(e -ell and e %etaolised

    • T(e ,ater e$*ands ot( C; and C; in

    *ro*ortion to t(eir +ol)%es

    • T(e C; +ol)%e ,ill in-rease y 333%l

    • ntra+as-)lar +ol)%e ,ill only in-rease y

    a**ro$i%ately 100%l

  • 8/20/2019 Perioperative Fluid Therapy.ppt

    27/36

    T(e ,olloids

    ,olloids are flids w(i.( .ontain on.oti.

    parti.les t(erefore eert an on.oti. pressre

    • Blood

    • =las!a•  &lb!in

    •  &rtifi.ial .olloids ) plas!a epander 

     ?

     ? H #6ydroyet(yl star.($ e/g/ (e%o(es 68 & 108

  • 8/20/2019 Perioperative Fluid Therapy.ppt

    28/36

    #olloids luid loading leads to greater increase in

     preload recruit table 4

  • 8/20/2019 Perioperative Fluid Therapy.ppt

    29/36

    5 Saline or colloids do not aect permeabilit$

    5 HS decrease permeabilit$ due to endothelial protections

    5 4"S 8 lung "nKur$ Score 6 ma$ slightl$ increase in colloid  

    estimated b$ L respirator$ compliance caused b$ increase"3(< which "< volume was included 8 increased volume dueto increased #OP 6

  • 8/20/2019 Perioperative Fluid Therapy.ppt

    30/36

  • 8/20/2019 Perioperative Fluid Therapy.ppt

    31/36

  • 8/20/2019 Perioperative Fluid Therapy.ppt

    32/36

    How should we monitor luid replacement!

    • (P, H7, =O

    • Filling pressures

    • 1astric pHi 

    • 3ransthoracic or transeophageal

    echo

    • 1oal?directed 7

  • 8/20/2019 Perioperative Fluid Therapy.ppt

    33/36

  • 8/20/2019 Perioperative Fluid Therapy.ppt

    34/36

    • C(e-# @ regi%e ordered in o* or%

    • Assess or dei-its y -(e-#ing &O -(art and +ital

    signs

    • Cal-)late %aintenan-e re)ire%ents

    • s)ally K9 not started in irst 24 (rs

    • Monitor -are)lly +ital signs and )rine o)t*)t

    • Cardia-: renal and li+er ail)re still %)stres)s-itate/ nd*oint are less *redi-tale: %onitor

    %ore intensi+ely =C n+asi+e %onitoring>

    =ostoperative flid t(erapy

    # l i

  • 8/20/2019 Perioperative Fluid Therapy.ppt

    35/36

    #onclusions G

    3arget o Fluid 3herap$ Perioperative

    5 Hemod$namic Optimalisation 9  "n acute emergenc$ resuscitation irst priorit$ J restoration

    o an adeuate circulating volume adeuate

    intravascular volume, DO:, blood pressure, adeuate

    Microcirculation 9  Over h$dration adverse outcome

    5 Optimal volume distribution

    5 Speciic losses should be replaced with appropriate luid 

    cr$stalloid 9 colloid, consider both solute, dissolve solute,electrol$te content, total osmolalit$, saet$, and side eect

  • 8/20/2019 Perioperative Fluid Therapy.ppt

    36/36